6-Acetoxy-4-chloro-7-methoxyquinazoline | CAS:230955-75-6

We serve 6-Acetoxy-4-chloro-7-methoxyquinazoline CAS:230955-75-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
6-Acetoxy-4-chloro-7-methoxyquinazoline

Chemical Name: 6-Acetoxy-4-chloro-7-methoxyquinazoline
CAS.NO:230955-75-6
Synonyms:
6-acetyloxy-7-methoxy-4-chloroquinazoline
4-Chloro-6-acetoxy-7-methoxyquinazoline
4-Chloro-7-methoxy-6-quinazolinol 6-acetate
6-Quinazolinol,4-chloro-7-Methoxy-,6-acetate
acetic acid 4-chloro-7-methoxyquinazolin-6-yl ester
Gefitinib interMediate V
4-Chloro-7-methoxyquinazolin-6-yl acetate
acetic acid 4-chloro-7-methoxy-6-quinazolinyl ester

Molecular Formula:C11H9ClN2O3
Molecular Weight:252.65400

Physical and Chemical Properties:
Density: 1.376 g / cm3
Boiling point: 364.609ºC at 760 mmHg
Melting point: /
Flash point: 174.309ºC
Refractive index: 1.605

Specification:
Appearance:Off-white or white powder
Purity:≥98%
Individual impurity≤0.5%
Total impurities≤1.0%
Loss on drying:≤0.5%
Residue on ignition:≤0.1%
Heavy metals:≤10ppm

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:-20°C Freezer.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Gefitinib CAS:184475-35-2



Contact us for information like 6-Acetoxy-4-chloro-7-methoxyquinazoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,acetic acid 4-chloro-7-methoxy-6-quinazolinyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chloro-7-methoxy-6-quinazolinol 6-acetate Use and application,Gefitinib interMediate V technical grade,usp/ep/jp grade.


Related News: It has reserves in the direction of APIs and intermediates for lowering blood lipids, lowering blood sugar and anticoagulation.Glycyrrhizic Acid Dipotassium Salt Hydrate manufacturer Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.3,5,6-Trichloropyridin-2-ol Sodium supplier Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.(E)-5-(2-CARBOMETHOXYVINYL)-2'-DEOXYURIDINE vendor This followed a declaration Thursday by the World Health Organization that the coronavirus outbreak is a Public Health Emergency of International Concern.Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.